VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
SLS
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
SLSSELLAS Life Sciences Group, Inc.
$13.50$1.9B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksSLSPrice History

SLS logoSELLAS Life Sciences Group, Inc. (SLS) Stock Price History

Historical prices from 2008 to 2026

$13.50-0.44  (-3.16%)close Jul 7
Returns
1M
+69.2%
3M
+199.3%
YTD
+210.3%
1Y
+522.1%
3Y
+101.9%
5Y
+9.7%
ATH$718,500.00Mar 2008-100.0%
ATL$0.50Jan 2024pre-split
Avg Vol (50D)9.3M/ day
52-Week Range$1.39 — $15.88
LowCurrent: $13.50High

Loading 10-year price history...

SLS Historical Performance

1 YearTotal Return
+522.1%
Price: +522.1%
3 YearsTotal Return
+723.2%
CAGR: +101.9%
Price: +723.2%
5 YearsTotal Return
+58.8%
CAGR: +9.7%
Price: +58.8%
YTD
+210.3%

SLS Annual Returns

Year-by-year price performance · 2008–2026

Best+252.3%2025
Worst-93.9%2019
Up years6/19
2008-45.3%
2009-23.7%
2010-37.1%
2011-81.9%
2012+225.5%
2013+211.9%
2014-70.3%
2015-5.8%
2016-93.3%
2017-86.9%
2018-81.6%
2019-93.9%
2020+42.4%
2021-1.4%
2022-59.7%
2023-58.4%
2024+15.6%
2025+252.3%
2026+13.3%
2008 annual price return
-45.3%
2009 annual price return
-23.7%
2010 annual price return
-37.1%
2011 annual price return
-81.9%
2012 annual price return
+225.5%
2013 annual price return
+211.9%
2014 annual price return
-70.3%
2015 annual price return
-5.8%
2016 annual price return
-93.3%
2017 annual price return
-86.9%
2018 annual price return
-81.6%
2019 annual price return
-93.9%
2020 annual price return
+42.4%
2021 annual price return
-1.4%
2022 annual price return
-59.7%
2023 annual price return
-58.4%
2024 annual price return
+15.6%
2025 annual price return
+252.3%
2026 annual price return
+13.3%
LessMore
Alpha vs S&P 500
1Y+397.2%
3Y+56.4%
5Y-19.1%

Price returns only.

Download Historical Data

4,609 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

SLS Stock Price Trajectory (2008–2026)

As of July 8, 2026, SELLAS Life Sciences Group, Inc. (SLS) trades at $13.50, representing a +522.1% return over the past year. The stock has delivered a +58.8% total return over five years (+9.7% CAGR), reflecting significant long-term value creation.

The stock reached its all-time high of $718,500.00 on March 12, 2008. From this peak, SLS has corrected -100.0%, currently trading 201% above its 200-day moving average, indicating continued institutional support.

When compared to Healthcare sector peers IMVT (+144.2% 1Y), ADMA (-48.5% 1Y), and NKTR (+219.1% 1Y), SLS has outperformed the peer group average. Compare SLS vs IMVT →

SLS Historical Price Data · from 2008

Rows 1–50 of 4,609
Date Open High Low Close Volume Change %
2026-07-0713.9013.9812.9213.508.09M-3.16%
2026-07-0614.7115.5313.7413.949.70M-6.94%
2026-07-0213.2015.0512.9514.9812.07M+12.89%
2026-07-0114.0314.4712.7513.2711.09M-10.09%
2026-06-3015.2215.8813.3414.7621.41M-4.47%
2026-06-2913.3315.6513.0315.4531.94M+24.70%
2026-06-2610.3912.4310.3212.390+17.66%
2026-06-259.2111.068.9810.5314.95M+14.83%
2026-06-249.259.328.829.174.48M+1.10%
2026-06-238.499.258.469.077.14M+6.33%
2026-06-228.388.888.348.538.03M+5.96%
2026-06-188.008.387.918.0511.05M+3.87%
2026-06-177.598.127.467.754.62M+2.92%
2026-06-167.607.857.437.534.27M-2.59%
2026-06-157.908.127.537.735.79M-1.28%
2026-06-127.678.137.607.834.04M+1.03%
2026-06-117.207.947.077.756.19M+8.39%
2026-06-107.617.707.117.156.60M-6.90%
2026-06-098.068.097.467.686.74M-3.76%
2026-06-088.518.537.957.985.83M-3.04%
2026-06-058.909.008.138.236.62M-8.96%
2026-06-048.119.227.979.048.28M+10.38%
2026-06-038.128.287.858.197.44M-1.68%
2026-06-028.999.008.238.3310.14M-8.16%
2026-06-019.099.298.789.077.24M-2.58%
2026-05-299.209.518.609.3125.81M+1.42%
2026-05-288.579.238.509.1810.06M+6.99%
2026-05-278.128.978.128.589.15M+5.67%
2026-05-267.878.367.418.128.67M+4.37%
2026-05-227.678.267.357.7810.63M+2.91%
2026-05-218.918.946.967.5624.65M-15.72%
2026-05-208.289.108.208.9718.15M+18.18%
2026-05-197.157.626.857.597.27M+4.12%
2026-05-187.367.607.107.298.83M+2.97%
2026-05-157.167.476.957.088.43M-4.58%
2026-05-146.487.806.257.4216.62M+13.63%
2026-05-136.326.725.686.5330.28M+25.10%
2026-05-125.195.285.035.222.82M-0.57%
2026-05-115.015.395.005.256.27M+4.79%
2026-05-084.975.034.845.013.34M+1.62%
2026-05-075.075.114.884.934.08M-4.27%
2026-05-064.945.174.935.153.50M+5.75%
2026-05-055.055.054.834.872.82M-2.99%
2026-05-044.935.244.925.023.84M+1.83%
2026-05-014.955.034.884.932.60M-0.40%
2026-04-304.745.024.714.953.74M+6.00%
2026-04-294.884.924.664.673.41M-4.30%
2026-04-284.824.924.734.883.26M0.00%
2026-04-274.745.024.634.886.46M+9.42%
2026-04-244.444.504.234.467.09M-3.88%
…
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

SLS — Frequently Asked Questions

Quick answers to the most common questions about buying SLS stock.

How has SLS stock performed recently?

SLS returned +522.1% over the past year, beating its 5-year annualized CAGR of +9.7%. The stock trades above its 200-day moving average, confirming the uptrend.

What is SLS's all-time high price?

SELLAS Life Sciences Group, Inc. reached $718500.00 on 2008-03-12. The 52-week high is $15.88. Current 1-year return of +522.1% places the stock closer to historical peaks.

Where can I download SLS historical price data?

This page provides SLS daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2008-2026, downloadable in CSV format.

462 data points · sampled from 4,609